Anne-Marie Koop

300 REFERENCES 1. Norozi K, Zoege M, Buchhorn R, Wessel A, Geyer S. The Influence of Congenital Heart Disease on Psychological. Congenit Heart Dis 2006;1:282–288. 2. Warnes CA, Bhatt AB, Daniels CJ, Gillam LD, Stout KK. COCATS 4 task force 14: Training in the care of adult patients with congenital heart disease. J Am Coll Cardiol Elsevier Inc; 2015;65:1887–1898. 3. Kato TS, Armstrong HF, Schulze PC, Lippel M, Amano A, Farr M, Bacchetta M, Bartels MN, Tullio MR Di, Homma S, Mancini D. Left and right ventricular functional dynamics determined by echocardiograms before and after lung transplantation. Am J Cardiol Elsevier Inc.; 2015;116:652–659. 4. Boer R a de, Daniels LB, Maisel AS, Januzzi JL. State of the art: newer biomarkers in heart failure. Eur J Heart Fail 2015;17:559–569. 5. Mueller C, McDonald K, Boer RA de, Maisel A, Cleland JGF, Kozhuharov N, Coats AJS, Metra M, Mebazaa A, Ruschitzka F, Lainscak M, Filippatos G, Seferovic PM, Meijers WC, Bayes-Genis A, Mueller T, Richards M, Januzzi JL. Heart FailureAssociation of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 2019;21:715–731. 6. ChowSL, Maisel AS, Anand I, Bozkurt B, Boer RA de, Felker GM, FonarowGC, Greenberg B, Januzzi JL, Kiernan MS, Liu PP, Wang TJ, Yancy CW, Zile MR, American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulm P and RC on E and PC on FG and TB and C on Q of C and OR. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2017;135:e1054–e1091. 7. Hartupee J, Mann DL. Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res 2013;6:485–492. 8. Sawada Y, Suda M, Yokoyama H, Kanda T, Sakamaki T, Tanaka S, Nagai R, Abe S, Takeuchi T. Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. J Biol Chem 1997;272:20545–20554. 9. Jumean MF, Kiernan MS. Determinants of survival following hospitalization for acute heart failure. Curr Heart Fail Rep 2014;11:201–211. 10. Frank Peacock W. Novel biomarkers in acute heart failure: MR-pro-adrenomedullin. Clin Chem Lab Med 2014;52:1433–1435. 11. Besler C, Lang D, Urban D, Rommel KP, Roeder M Von, Fengler K, Blazek S, Kandolf R, Klingel K, Thiele H, Linke A, Schuler G, Adams V, Lurz P. Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: Implications for its use as a biomarker. Circ Hear Fail 2017;10:1–9. 12. Kempf T, Haehling S von, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure. J Am Coll Car diol 2007;50:1054–1060.